Terms: = Leukemia AND TRIM24, O15164, 8805, ENSG00000122779, TIF1ALPHA, TF1A, TIF1A, hTIF1, Tif1a, TIF1, RNF82, PTC6
31 results:
1. [Effect of miR-22 Targeting
Liu J; Zhang JG; Sun Y; Qiu L; Yang Y; Yang R; Jin Y; Li CM; Jiang DL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1617-1623. PubMed ID: 38071036
[TBL] [Abstract] [Full Text] [Related]
2. Nuclear Proteomics of Induced leukemia Cell Differentiation.
Novikova S; Tolstova T; Kurbatov L; Farafonova T; Tikhonova O; Soloveva N; Rusanov A; Archakov A; Zgoda V
Cells; 2022 Oct; 11(20):. PubMed ID: 36291090
[TBL] [Abstract] [Full Text] [Related]
3. Branched I antigen regulated cell susceptibility against natural killer cytotoxicity through its N-linked glycosylation and overall expression.
Wu YX; Lu HF; Lin YH; Chuang HY; Su SC; Liao YJ; Twu YC
Glycobiology; 2021 Jun; 31(5):624-635. PubMed ID: 33403394
[TBL] [Abstract] [Full Text] [Related]
4. trim24 and Trim33 Play a Role in Epigenetic Silencing of Retroviruses in Embryonic Stem Cells.
Margalit L; Strauss C; Tal A; Schlesinger S
Viruses; 2020 Sep; 12(9):. PubMed ID: 32932986
[TBL] [Abstract] [Full Text] [Related]
5. Knockdown of trim24 suppresses growth and induces apoptosis in acute myeloid leukemia through downregulation of Wnt/GSK-3β/β-catenin signaling.
Li C; Xin H; Shi Y; Mu J
Hum Exp Toxicol; 2020 Dec; 39(12):1725-1736. PubMed ID: 32672070
[TBL] [Abstract] [Full Text] [Related]
6. Involvement of pRb-E2F pathway in green tea extract-induced growth inhibition of human myeloid leukemia cells.
Henry D; Brumaire S; Hu X
Leuk Res; 2019 Feb; 77():34-41. PubMed ID: 30641474
[TBL] [Abstract] [Full Text] [Related]
7. PTEN is indispensable for cells to respond to MAPK inhibitors in myeloid leukemia.
Zhang J; Xiang Z; Malaviarachchi PA; Yan Y; Baltz NJ; Emanuel PD; Liu YL
Cell Signal; 2018 Oct; 50():72-79. PubMed ID: 29964149
[TBL] [Abstract] [Full Text] [Related]
8. Functional trim24 degrader via conjugation of ineffectual bromodomain and VHL ligands.
Gechijian LN; Buckley DL; Lawlor MA; Reyes JM; Paulk J; Ott CJ; Winter GE; Erb MA; Scott TG; Xu M; Seo HS; Dhe-Paganon S; Kwiatkowski NP; Perry JA; Qi J; Gray NS; Bradner JE
Nat Chem Biol; 2018 Apr; 14(4):405-412. PubMed ID: 29507391
[TBL] [Abstract] [Full Text] [Related]
9. Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual trim24-BRPF1 Bromodomain Inhibitor.
Palmer WS; Poncet-Montange G; Liu G; Petrocchi A; Reyna N; Subramanian G; Theroff J; Yau A; Kost-Alimova M; Bardenhagen JP; Leo E; Shepard HE; Tieu TN; Shi X; Zhan Y; Zhao S; Barton MC; Draetta G; Toniatti C; Jones P; Geck Do M; Andersen JN
J Med Chem; 2016 Feb; 59(4):1440-54. PubMed ID: 26061247
[TBL] [Abstract] [Full Text] [Related]
10. trim24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice.
Jiang S; Minter LC; Stratton SA; Yang P; Abbas HA; Akdemir ZC; Pant V; Post S; Gagea M; Lee RG; Lozano G; Barton MC
J Hepatol; 2015 Feb; 62(2):371-9. PubMed ID: 25281858
[TBL] [Abstract] [Full Text] [Related]
11. Eliminating malignant contamination from therapeutic human spermatogonial stem cells.
Dovey SL; Valli H; Hermann BP; Sukhwani M; Donohue J; Castro CA; Chu T; Sanfilippo JS; Orwig KE
J Clin Invest; 2013 Apr; 123(4):1833-43. PubMed ID: 23549087
[TBL] [Abstract] [Full Text] [Related]
12. Cyclopamine and jervine induce COX-2 overexpression in human erythroleukemia cells but only cyclopamine has a pro-apoptotic effect.
Ghezali L; Leger DY; Limami Y; Cook-Moreau J; Beneytout JL; Liagre B
Exp Cell Res; 2013 Apr; 319(7):1043-53. PubMed ID: 23357584
[TBL] [Abstract] [Full Text] [Related]
13. Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in Acute Myeloid Leukaemia.
Jawad M; Yu N; Seedhouse C; Tandon K; Russell NH; Pallis M
BMC Cancer; 2012 Sep; 12():431. PubMed ID: 23013471
[TBL] [Abstract] [Full Text] [Related]
14. Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia.
Silveira VS; Scrideli CA; Moreno DA; Yunes JA; Queiroz RG; Toledo SC; Lee ML; Petrilli AS; Brandalise SR; Tone LG
Leuk Lymphoma; 2013 Feb; 54(2):310-4. PubMed ID: 22897724
[TBL] [Abstract] [Full Text] [Related]
15. TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other TRIM family members.
Bell JL; Malyukova A; Holien JK; Koach J; Parker MW; Kavallaris M; Marshall GM; Cheung BB
PLoS One; 2012; 7(5):e37470. PubMed ID: 22629402
[TBL] [Abstract] [Full Text] [Related]
16. Reverse phase protein array profiling reveals distinct proteomic signatures associated with chronic myeloid leukemia progression and with chronic phase in the CD34-positive compartment.
Quintás-Cardama A; Qiu YH; Post SM; Zhang Y; Creighton CJ; Cortes J; Kornblau SM
Cancer; 2012 Nov; 118(21):5283-92. PubMed ID: 22517119
[TBL] [Abstract] [Full Text] [Related]
17. TRIM involvement in transcriptional regulation.
Cammas F; Khetchoumian K; Chambon P; Losson R
Adv Exp Med Biol; 2012; 770():59-76. PubMed ID: 23631000
[TBL] [Abstract] [Full Text] [Related]
18. Adenovirus E4orf3 targets transcriptional intermediary factor 1γ for proteasome-dependent degradation during infection.
Forrester NA; Patel RN; Speiseder T; Groitl P; Sedgwick GG; Shimwell NJ; Seed RI; Catnaigh PÓ; McCabe CJ; Stewart GS; Dobner T; Grand RJ; Martin A; Turnell AS
J Virol; 2012 Mar; 86(6):3167-79. PubMed ID: 22205733
[TBL] [Abstract] [Full Text] [Related]
19. Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood.
Pillon M; Aricò M; Basso G; Locatelli F; Citterio M; Micalizzi C; Testi AM; Barisone E; Nardi M; Lombardi A; Rondelli R; Rosolen A;
Pediatr Blood Cancer; 2011 Apr; 56(4):544-50. PubMed ID: 21298738
[TBL] [Abstract] [Full Text] [Related]
20. The adenovirus E4 ORF3 protein binds and reorganizes the TRIM family member transcriptional intermediary factor 1 alpha.
Yondola MA; Hearing P
J Virol; 2007 Apr; 81(8):4264-71. PubMed ID: 17287283
[TBL] [Abstract] [Full Text] [Related]
[Next]
